Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Mimetic Chromatography provides consultancy and analytical services using high performance liquid chromatography (HPLC) with biomimetic stationary phases to predict in vivo distribution properties of drug candidates. Their approach accelerates drug discovery by enabling early assessment of membrane/protein binding and other ADME-relevant parameters. The company is led by Professor Klara Valko, an expert with over 22 years at GSK.[1][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Mimetic Chromatography.